Market icon

JN.1 most common COVID variant in US by Dec 23?

>99% chance

$3,923 Umsatz

Regeln

This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
Volumen
$3,923
Enddatum
Dec 23, 2023
Erstellt am
Dec 19, 2023, 12:57 PM ET

Ergebnis vorgeschlagen: Yes

Kein Widerspruch

Endgültiges Ergebnis: Yes

Vorsicht vor externen Links.

Market icon

JN.1 most common COVID variant in US by Dec 23?

>99% chance

$3,923 Umsatz

Über

This market will resolve to "Yes" if the JN.1 variant of SARS-CoV-2 is responsible for the most COVID-19 cases by proportion in the United States according to CDC's Nowcast at the time of its next release (after 12/9/23). Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Nowcast Estimates in the United States for 12/23/23 as soon as released (% Total column in graph here https://covid.cdc.gov/covid-data-tracker/#variant-proportions). This market will resolve based on the initial information release by the CDC regardless of later information updates. If the CDC stops reporting figures for COVID-19 or ceases to utilize the Nowcast before the end of this market, it will resolve 50-50.
Volumen
$3,923
Enddatum
Dec 23, 2023
Erstellt am
Dec 19, 2023, 12:57 PM ET

Ergebnis vorgeschlagen: Yes

Kein Widerspruch

Endgültiges Ergebnis: Yes

Vorsicht vor externen Links.